GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Price-to-Owner-Earnings

Rising Biosciences (Rising Biosciences) Price-to-Owner-Earnings : (As of Jun. 17, 2024)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Price-to-Owner-Earnings?

As of today (2024-06-17), Rising Biosciences's share price is $0.0001. Rising Biosciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Rising Biosciences's Price-to-Owner-Earnings or its related term are showing as below:


RBII's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.33
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-17), Rising Biosciences's share price is $0.0001. Rising Biosciences does not have enough years/quarters to calculate the Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate PE Ratio at this moment.

As of today (2024-06-17), Rising Biosciences's share price is $0.0001. Rising Biosciences does not have enough years/quarters to calculate the EPS without NRI for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate PE Ratio without NRI at this moment.


Rising Biosciences Price-to-Owner-Earnings Historical Data

The historical data trend for Rising Biosciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Price-to-Owner-Earnings Chart

Rising Biosciences Annual Data
Trend
Price-to-Owner-Earnings

Rising Biosciences Quarterly Data
Price-to-Owner-Earnings

Competitive Comparison of Rising Biosciences's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rising Biosciences's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Price-to-Owner-Earnings falls into.



Rising Biosciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Rising Biosciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0001/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rising Biosciences  (GREY:RBII) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Rising Biosciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

Rising Biosciences Set To Acquire All Assets from PAO Group

By Marketwired Marketwired 11-07-2018

PAOG Officially Appoints Karl Riedel as New CEO and President

By Marketwired Marketwired 02-11-2019